Loading page content…
Loading page content…
| Source: | Find a Tender Service (FTS) |
| Buyer: | Mid South Essex NHS Foundation Trust |
| Main Category: | Goods |
| Procurement Method: | Open procedure |
| Tender Status: | Active |
| Estimated Value (ex. VAT): | £850,000,000 |
| Estimated Value (inc. VAT): | £850,000,000 |
| Release Date: |
Pipeline status
Not addedContract imported automatically · AI writes the response
Application Deadline
11 May 2026
25 days left
Estimated Value
£850,000,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| 13 April 2026 |
| Application Deadline: | 11 May 2026 |
| Enquiry Deadline: | 1 May 2026 |
| Contract Start Date: | 31 August 2026 (Estimated) |
| Contract End Date: | 30 August 2034 (Estimated) |
| Contract Duration: | 8.1 years |
| Procurement ID (OCID): | ocds-h6vhtk-051cde |
| Notice Reference: | 033144-2026 |
Ready to bid on this contract?
BidWriter AI writes your tender response in minutes — import this contract in one click.
View Original Notice
Access the full notice on the official portal
This framework agreement is for the supply of a range of aseptically prepared, batch manufactured systemic anti-cancer therapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific systemic anti-cancer therapy drugs, CIVAs, and provisions for stock inventory management and supply of compounded systemic anti-cancer therapy.
Document pack· 1 file
Published contracts in the last 12 months
48
total contracts
£4733.3m
total value
£262,962,963
average contract size
Typical categories